Management of diabetes in patients with COVID-19 – Authors' reply
Stefan R. Bornstein, Paul Zimmet, Francesco Rubino, Barbara Ludwig
Topics & Concepts
MedicineMetforminPioglitazoneDiabetes mellitusCoronavirus disease 2019 (COVID-19)DiseaseType 2 diabetesIntensive care medicineMEDLINERosiglitazonePharmacologyInternal medicineBioinformaticsEndocrinologyInfectious disease (medical specialty)LawBiologyPolitical scienceCOVID-19 Clinical Research StudiesAdipokines, Inflammation, and Metabolic DiseasesMetabolism, Diabetes, and Cancer